A study to evaluate the benefit of omeprazole in the prevention of bleeding from esophageal ulcer after esophageal varices

A study to evaluate the benefit of omeprazole in the prevention of bleeding from esophageal ulcer after esophageal varices - A study to evaluate the benefit of omeprazole in the prevention of bleeding from esophageal ulcer after esophageal varices

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005749

Enrollment

Registered

2011-06-13

Start date

2011-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with esophageal ulcer (no less than 20 years old)

Interventions

omeprazol famotidine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with esophageal ulcer

Exclusion criteria

Exclusion criteria: 1) Patients with previous partial gastrectomy or vagotomy 2) Patients with sever cerebral, cardiac, renal, or hematopoietic dysfunction 3) Patients with contraindications to any test drugs 4) Pregnant or lactating women or women who plan to become pregnant during the study

Design outcomes

Primary

Measure	Time frame
Ulcer healing rate, Esophagostenosis, GOS score	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026